Your browser doesn't support javascript.
loading
LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
Shropshire, Erin L; Chaudhry, Mohammad; Miller, Chad M; Allen, Brian C; Bozdogan, Erol; Cardona, Diana M; King, Lindsay Y; Janas, Gemini L; Do, Richard K; Kim, Charles Y; Ronald, James; Bashir, Mustafa R.
Afiliación
  • Shropshire EL; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Chaudhry M; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Miller CM; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Allen BC; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Bozdogan E; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Cardona DM; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • King LY; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Janas GL; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Do RK; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Kim CY; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Ronald J; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
  • Bashir MR; From the Department of Radiology (E.L.S., M.C., C.M.M., B.C.A., E.B., G.L.J., C.Y.K., J.R., M.R.B.), Department of Pathology (D.M.C.), Division of Gastroenterology, Department of Medicine (L.Y.K., M.R.B.), and Center for Advanced Magnetic Resonance Development (G.L.J., M.R.B.), Duke University Medic
Radiology ; 292(1): 226-234, 2019 07.
Article en En | MEDLINE | ID: mdl-31038409
Background In 2017, the Liver Imaging Reporting and Data System (LI-RADS) included an algorithm for the assessment of hepatocellular carcinoma (HCC) treated with local-regional therapy. The aim of the algorithm was to enable standardized evaluation of treatment response to guide subsequent therapy. However, the performance of the algorithm has not yet been validated in the literature. Purpose To evaluate the performance of the LI-RADS 2017 Treatment Response algorithm for assessing the histopathologic viability of HCC treated with bland arterial embolization. Materials and Methods This retrospective study included patients who underwent bland arterial embolization for HCC between 2006 and 2016 and subsequent liver transplantation. Three radiologists independently assessed all treated lesions by using the CT/MRI LI-RADS 2017 Treatment Response algorithm. Radiology and posttransplant histopathology reports were then compared. Lesions were categorized on the basis of explant pathologic findings as either completely (100%) or incompletely (<100%) necrotic, and performance characteristics and predictive values for the LI-RADS Treatment Response (LR-TR) Viable and Nonviable categories were calculated for each reader. Interreader association was calculated by using the Fleiss κ. Results A total of 45 adults (mean age, 57.1 years ± 8.2; 13 women) with 63 total lesions were included. For predicting incomplete histopathologic tumor necrosis, the accuracy of the LR-TR Viable category for the three readers was 60%-65%, and the positive predictive value was 86%-96%. For predicting complete histopathologic tumor necrosis, the accuracy of the LR-TR Nonviable category was 67%-71%, and the negative predictive value was 81%-87%. By consensus, 17 (27%) of 63 lesions were categorized as LR-TR Equivocal, and 12 of these lesions were incompletely necrotic. Interreader association for the LR-TR category was moderate (κ = 0.55; 95% confidence interval: 0.47, 0.67). Conclusion The Liver Imaging Reporting and Data System 2017 Treatment Response algorithm had high predictive value and moderate interreader association for the histopathologic viability of hepatocellular carcinoma treated with bland arterial embolization when lesions were assessed as Viable or Nonviable. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Gervais in this issue.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Sistemas de Información Radiológica / Carcinoma Hepatocelular / Embolización Terapéutica / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiology Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Sistemas de Información Radiológica / Carcinoma Hepatocelular / Embolización Terapéutica / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiology Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos